Substance P activates the wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6224-6240

  Mei, Gang ^a   Zou, Zhenlv ^a   Fu, Su ^a   Xia, Liheng ^a   Zhou, Jian ^a   Zhang, Yongtao ^a   Tuo, Yonghua ^b   Wang, Zhao ^c   Jin, Dan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Wuzhou Red Cross Hospital   (China)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Differentiation; Mc3t3 e1 cells; Substance p; Wnt signal transduction pathway

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; COLLAGEN TYPE 1; CYCLIN D1; DICKKOPF 1 PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; NEUROKININ 1 RECEPTOR ANTAGONIST; OSTEOCALCIN; SUBSTANCE P; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; OSTEOBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; MICE; OSTEOBLASTS; OSTEOGENESIS; RNA, MESSENGER; SUBSTANCE P; UP-REGULATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84898655709     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046224     Document Type: Article

References (41)

1. Bjurholm, A.; Kreicbergs, A.; Brodin, E.; Schultzberg, M. Substance P-and CGRP-immunoreactive nerves in bone. Peptides 1988, 9, 165-171.
2. Lundberg, P.; Lundgren, I.; Mukohyama, H.; Lehenkari, P.P.; Horton, M.A.; Lerner, U.H. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: Presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. Endocrinology 2001, 142, 339-347.
3. Tuo, Y.; Guo, X.; Zhang, X.; Wang, Z.; Zhou, J.; Xia, L.; Zhang, Y.; Wen, J.; Jin, D. The biological effects and mechanisms of calcitonin gene-related peptide on human endothelial cell. J. Recept. Signal Transduct. Res. 2013, 33, 114-123.
4. An, Y.S.; Lee, E.; Kang, M.H.; Hong, H.S.; Kim, M.R.; Jang, W.S.; Son, Y.; Yi, J.Y. Substance P stimulates the recovery of bone marrow after the irradiation. J. Cell. Physiol. 2011, 226, 1204-1213.
5. Malkesman, O.; Braw, Y.; Weller, A. Assessment of antidepressant and anxiolytic properties of NK1 antagonists and substance P in Wistar Kyoto rats. Physiol. Behav. 2007, 90, 619-625.
6. Delgado, A.V.; McManus, A.T.; Chambers, J.P. Production of tumor necrosis factor-α, interleukin 1-β, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 2003, 37, 355-361.
7. Marolda, R.; Ciotti, M.T.; Matrone, C.; Possenti, R.; Calissano, P.; Cavallaro, S.; Severini, C. Substance P activates ADAM9 mRNA expression and induces α-secretase-mediated amyloid precursor protein cleavage. Neuropharmacology 2012, 62, 1954-1963.
8. Goto, T.; Tanaka, T. Tachykinins and tachykinin receptors in bone. Microsc. Res. Tech. 2002, 58, 91-97.
9. Goto, T.; Nakao, K.; Gunjigake, K.K.; Kido, M.A.; Kobayashi, S.; Tanaka, T. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 2007, 41, 25-31.
10. Shih, C.; Bernard, G.W. Neurogenic substance P stimulates osteogenesis in vitro. Peptides 1997, 18, 323-326.
11. Sohn, S.J. Substance P upregulates osteoclastogenesis by activating nuclear factor κB in osteoclast precursors. Acta Otolaryngol. 2005, 125, 130-133.
12. Wang, L.; Zhao, R.; Shi, X.; Wei, T.; Halloran, B.P.; Clark, D.J.; Jacobs, C.R.; Kingery, W.S. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 2009, 45, 309-320.
13. Kim, S.Y.; Kim, S.; Yun-Choi, H.S.; Jho, E.H. Wnt5a potentiates U46619-induced platelet aggregation via the PI3K/Akt pathway. Mol. Cells 2011, 32, 333-336.
14. Zheng, Q.; Chen, P.; Xu, Z.; Li, F.; Yi, X.P. Expression and redistribution of β-catenin in the cardiac myocytes of left ventricle of spontaneously hypertensive rat. J. Mol. Histol. 2013, 44, 565-573.
15. Peterson-Nedry, W.; Erdeniz, N.; Kremer, S.; Yu, J.; Baig-Lewis, S.; Wehrli, M. Unexpectedly robust assembly of the Axin destruction complex regulates Wnt/Wg signaling in Drosophila as revealed by analysis in vivo. Dev. Biol. 2008, 320, 226-241.
16. Li, J.; Li, J.; Chen, B. Oct4 was a novel target of Wnt signaling pathway. Mol. Cell. Biochem. 2012, 362, 233-240.
17. Sun, Y.C. Examination of effects of GSK3β phosphorylation, β-catenin phosphorylation, and β-catenin degradation on kinetics of Wnt signaling pathway using computational method. Theor. Biol. Med. Model. 2009, doi:10.1186/1742-4682-6-13.
18. Lee, J.H.; Kim, B.G.; Ahn, J.M.; Park, H.J.; Park, S.K.; Yoo, J.S.; Yates, J.R.; Cho, J.Y. Role of PI3K on the regulation of BMP2-induced β-catenin activation in human bone marrow stem cells. Bone 2010, 46, 1522-1532.
19. MacDonald, B.T.; Tamai, K.; He, X. Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev. Cell 2009, 17, 9-26.
20. Fleury, D.; Vayssiere, B.; Touitou, R.; Gillard, C.; Lebhar, H.; Rawadi, G.; Mollat, P. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6. Protein Expr. Purif. 2010, 70, 39-47.
21. Georgiou, K.R.; King, T.J.; Scherer, M.A.; Zhou, H.; Foster, B.K.; Xian, C.J. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats. Bone 2012, 50, 1223-1233.
22. Tamura, M.; Sato, M.M.; Nashimoto, M. Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells. Int. J. Biochem. Cell Biol. 2011, 43, 760-767.
23. Guo, J.; Liu, M.; Yang, D.; Bouxsein, M.L.; Saito, H.; Galvin, R.J.; Kuhstoss, S.A.; Thomas, C.C.; Schipani, E.; Baron, R., et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 2010, 11, 161-171.
24. Wang, L.; Shi, X.; Zhao, R.; Halloran, B.P.; Clark, D.J.; Jacobs, C.R.; Kingery, W.S. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-κB activation, osteoclastogenesis and bone resorption. Bone 2010, 46, 1369-1379.
25. Zhang, M.; Yan, Y.; Lim, Y.B.; Tang, D.; Xie, R.; Chen, A.; Tai, P.; Harris, S.E.; Xing, L.; Qin, Y.X., et al. BMP-2 modulates β-catenin signaling through stimulation of Lrp5 expression and inhibition of β-TrCP expression in osteoblasts. J. Cell. Biochem. 2009, 108, 896-905.
26. Lee, E.; Salic, A.; Kruger, R.; Heinrich, R.; Kirschner, M.W. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 2003, 1, e10.
27. Kestler, H.A.; Kuhl, M. From individual Wnt pathways towards a Wnt signalling network. Philos. Trans. R. Soc. 2008, 363, 1333-1347.
28. Cho, K.H.; Baek, S.; Sung, M.H. Wnt pathway mutations selected by optimal β-catenin signaling for tumorigenesis. FEBS Lett. 2006, 580, 3665-3670.
29. Hoppler, S.; Kavanagh, C.L. Wnt signalling: Variety at the core. J. Cell Sci. 2007, 120, 385-393.
30. Lee, J.E.; Wu, S.F.; Goering, L.M.; Dorsky, R.I. Canonical Wnt signaling through Lef1 is required for hypothalamic neurogenesis. Development 2006, 133, 4451-4461.
31. Barolo, S. Transgenic Wnt/TCF pathway reporters: All you need is Lef? Oncogene 2006, 25, 7505-7511.
32. Shimizu, N.; Kawakami, K.; Ishitani, T. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish. Dev. Biol. 2012, 370, 71-85.
33. Vlad, A.; Rohrs, S.; Klein-Hitpass, L.; Muller, O. The first five years of the Wnt targetome. Cell Signal. 2008, 20, 795-802.
34. Logan, C.Y.; Nusse, R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20, 781-810.
35. Juan, J.; Muraguchi, T.; Iezza, G.; Sears, R.C.; McMahon, M. Diminished WNT → β-catenin → c-myc signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes Dev. 2014, 28, 561-575.
36. Sukhotnik, I.; Roitburt, A.; Pollak, Y.; Dorfman, T.; Matter, I.; Mogilner, J.G.; Bejar, J.; Coran, A.G. Wnt/β-catenin signaling cascade down-regulation following massive small bowel resection in a rat. Pediatr. Surg. Int. 2014, 30, 173-180.
37. Ramnath, R.D.; Sun, J.; Adhikari, S.; Bhatia, M. Effect of mitogen-activated protein kinases on chemokine synthesis induced by substance P in mouse pancreatic acinar cells. J. Cell. Mol. Med. 2007, 11, 1326-1341.
38. Schmidt, P.T.; Rasmussen, T.N.; Holst, J.J. Tachykinins may mediate capsaicin-induced, but not vagally induced motility in porcine antrum. Peptides 1997, 18, 1511-1516.
39. Sharon, N.; Mor, I.; Golan-lev, T.; Fainsod, A.; Benvenisty, N. Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells 2011, 29, 600-608.
40. Alcantara, E.H.; Shin, M.Y.; Sohn, H.Y.; Park, Y.M.; Kim, T.; Lim, J.H.; Jeong, H.J.; Kwon, S.T.; Kwun, I.S. Diosgenin stimulates osteogenic activity by increasing bone matrix protein synthesis and bone-specific transcription factor Runx2 in osteoblastic MC3T3-E1 cells. J. Nutr. Biochem. 2011, 22, 1055-1063.
41. Dong, J.; He, Y.; Zhang, X.; Wang, L.; Sun, T.; Zhang, M.; Liang, Y.; Qi, M. Calcitonin gene-related peptide regulates the growth of epidermal stem cells in vitro. Peptides 2010, 31, 1860-1865.